Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550554

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1550554

Global Analgesics Market, By Drug Type, By Route of Administration, By Application, By Pain Type, By Distribution Channel, By Geography

PUBLISHED:
PAGES: 170 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

Global analgesics market is estimated to be valued at USD 51.10 Bn in 2024 and is expected to reach USD 79.51 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 51.10 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 6.50% 2031 Value Projection: US$ 79.51 Bn
Figure. Global Analgesics Market Share (%), By Region 2024
Global Analgesics Market - IMG1

Global analgesics market growth is driven by rising prevalence of chronic and acute pain disorders worldwide. Analgesics drugs play a crucial role in relieving pain and enhancing the quality of life of patients. Changing lifestyles and higher stress levels have significantly increased several pain-related ailments like backache, arthritis, and migraines among others. Technological advancements in drug delivery systems and formulation development have boosted demand for novel analgesic medications with improved efficacy and reduced risk of addiction. Moreover, growing geriatric population prone to osteoarthritis and musculoskeletal disorders can also boost demand for analgesics. However, strict regulations surrounding opioid medications and development of alternative therapies can pose challenges to industry players.

Market Dynamics:

Global analgesics market growth is primarily driven by rising prevalence of various pain-related chronic conditions like arthritis, back pain, migraines, and osteoporosis due to growing geriatric population worldwide. As per estimates, over 20% of the global population will suffer from osteoarthritis by 2030. Changing lifestyles with sedentary jobs and increased stress levels have substantially raised the incidence of musculosketal disorders, thus, boosting demand for analgesic. However, growing concerns over misuse and abuse of prescription opioids can hamper the market growth. This has led regulatory bodies to tighten rules surrounding opioid analgesic approvals and usage. Moreover, alternative therapies like cannabinoid-based drugs, acupuncture, and physiotherapy are gaining popularity, and this can hamper demand for traditional painkillers. Favorable reimbursement policies for chronic pain management provides profitable opportunities for analgesic manufacturers. Ongoing research towards develop non-addictive formulas and advanced drug delivery systems can offer growth opportunities in the future.

Key Features of the Study:

This report provides in-depth analysis of the global analgesics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global analgesics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, GSK, Novartis, and Johnson & Johnson.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global analgesics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global analgesics market

Detailed Segmentation-

  • By Drug Type
    • Opioid
    • Non-opioid
    • Compound medication
  • By Route of Administration
    • Oral
    • Parenteral
    • Transdermal
    • Others
  • By Application
    • Musculoskeletal
    • Surgical and Trauma
    • Cancer
    • Neuropathic
    • Migraine
    • Obstetrical
    • Fibromyalgia
    • Pain due to Burns
    • Dental/Facial
    • Pediatric
    • Others
  • By Pain Type
    • Acute
    • Chronic
  • By Distribution Channel
    • Hospital pharmacies
    • Retail pharmacies
    • Online pharmacies
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • F. Hoffmann-La Roche Ltd.
    • Mylan N.V.
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Novartis AG
    • Merck & Co., Inc.
    • AstraZeneca
    • Johnson & Johnson Private Limited
    • Hikma Pharmaceuticals PLC
    • Reddy's Laboratories Ltd.
    • Fresenius Kabi AG
    • Aurobindo Pharma
    • Bausch Health Companies Inc.
    • Amneal Pharmaceuticals LLC.
    • Apotex Inc.
    • Eli Lilly and Company
    • Cipla Inc.
    • Lupin
Product Code: CMI7207

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Type
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Application
    • Market Snapshot, By Pain Type
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Analgesics Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Analgesics Market, By Drug Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Opioid
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Non-opioid
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Compound medication
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Analgesics Market, By Route of Administration, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Oral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Parenteral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Transdermal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Analgesics Market, By Application, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Musculoskeletal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Surgical and Trauma
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Neuropathic
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Migraine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Obstetrical
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Fibromyalgia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Pain due to Burns
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Dental/Facial
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Pediatric
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Analgesics Market, By Pain Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Acute
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Chronic
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Analgesics Market, By Distribution Channel, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hospital pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Retail pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Online pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

10. Global Analgesics Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
      • Africa
      • North Africa
      • Central Africa
      • South Africa

11. Competitive Landscape

  • Company Profiles
    • F. Hoffmann-La Roche Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Mylan N.V.
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Novartis AG
    • Merck & Co., Inc.
    • AstraZeneca
    • Johnson & Johnson Private Limited
    • Hikma Pharmaceuticals PLC
    • Dr. Reddy's Laboratories Ltd.
    • Fresenius Kabi AG
    • Aurobindo Pharma
    • Bausch Health Companies Inc.
    • Amneal Pharmaceuticals LLC.
    • Apotex Inc.
    • Eli Lilly and Company
    • Cipla Inc.
    • Lupin

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!